Melasma Clinical Trials

Find Melasma Clinical Trials Near You

A Monocentric and Open-Label Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Research Participants

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Able to understand and follow study instructions

• Fitzpatrick skin types I-VI

• Presence of facial hyperpigmentation, such as:

‣ Mild to moderate melasma, or

⁃ Visible dark spots (e.g., solar lentigines or post-inflammatory hyperpigmentation)

• Willing to comply with study procedures and product use

• For subjects in applicable groups: willing to use assigned sunscreen product

Locations
Other Locations
Brazil
ALS Beauty & Personal Care Ltda
RECRUITING
Campinas
Contact Information
Primary
Kenvue Global Clinical Operations
KenvueClinical_KV@kenvue.com
18779295131
Time Frame
Start Date: 2026-06-02
Estimated Completion Date: 2026-09-25
Participants
Target number of participants: 152
Treatments
Experimental: Group I: Melasma/Untinted
Experimental: Group I: Melasma/Tinted
Experimental: Group II: Solar Lentigo and Post-Inflammatory Hyperpigmentation / Untinted
Experimental: Group II: Solar Lentigo and Post-Inflammatory Hyperpigmentation / Tinted
Related Therapeutic Areas
Sponsors
Leads: Kenvue Brands LLC

This content was sourced from clinicaltrials.gov